Official announcement from the National Institute of Allergy and Infectious Diseases (NIAID) or peer-reviewed publications

Pre-Pregnancy Malaria Vaccine Shows Promise in Mali Trials

Aug 15, 2024, 06:26 AM

Recent findings from a trial conducted in Mali indicate that a pre-pregnancy malaria vaccine, known as the PfSPZ Vaccine, could significantly protect women and their babies from malaria. The research, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), involved two randomized, double-blind, placebo-controlled phase 1 and 2 trials. Scientists have hailed the results as a 'tremendous advance' in preventing the deadly parasitic disease in pregnant women. The trial's success could pave the way for improved malaria prevention strategies for women anticipating pregnancy.